Metabolic diseases represent an extremely broad spectrum of diseases, including metabolic bone diseases. These can result in fragility and fractures. Osteoporosis and sarcopenia, for example, have a major impact on healthcare systems, as well as on patients' quality of life.

Despite metabolic changes happen at a molecular level, the understanding of metabolic bone diseases relies more and more on imaging. This is true in both research and clinical practice. Imaging is capable to assess (and sometimes discover) different in-vivo biomarkers of metabolism and frailty, aside from detecting fractures (sometimes this poses a challenge).

Imaging is making visible what was invisible or impossible to assess only a few years ago, with new techniques and tools in clinical practice.

This course will be focused on translating science into practice in the field of metabolic bone disease diagnosis and management, in the light of modern imaging. Special attention will be put on the take home messages, aiming to integrate the clinical practice of different professionals working in the field, with the goal of improving diagnosis and management of MSK frailty.

This will be possible with the invaluable contribution of several internationally acclaimed and
credited experts in the field.

Maximum number of participants: 70.

English is the official language of the Course. Simultaneous translation is not provided.

Referents

Scientific Responsible Chairman

051-6366836 (segreteria)

alberto.bazzocchi@ior.it

Bazzocchi Alberto, MD, PhD

MD

Diagnostic and Interventional Radiology